Qiaobin Guan Selected Research

N- (2- (4- (4- chlorophenyl)piperazin- 1- yl)ethyl)- 3- methoxybenzamide (PB 12)

1/2018

The prognostic correlation between CD105 expression level in tumor tissue and peripheral blood and sunitinib administration in advanced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiaobin Guan Research Topics

Disease

1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Tremor (Tremors) 01/2018

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	N- (2- (4- (4- chlorophenyl)piperazin- 1- yl)ethyl)- 3- methoxybenzamide (PB 12)IBA 01/2018
1	Myeloid Differentiation Factor 88IBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2018